QT
VCYT icon

Quantamental Technologies’s Veracyte VCYT Stock Holding History

Quantamental Technologies’s Portfolio VCYT Stock Details VCYT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-11,877
Closed -$282K – 624
2022
Q4 		$282K Buy
+11,877
New +$276K 0.13% 275
2022
Q3 		– Sell
-11,612
Closed -$231K – 674
2022
Q2 		$231K Buy
11,612
+3,775
+48% +$76.3K 0.11% 321
2022
Q1 		$216K Buy
+7,837
New +$224K 0.12% 308
2021
Q4 		– Sell
-5,935
Closed -$276K – 505
2021
Q3 		$276K Buy
+5,935
New +$259K 0.18% 189

Other funds holding VCYT

AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return

Quantamental Technologies's VCYT Position: Q1 2023 in Review

Quantamental Technologies sold out of Veracyte (VCYT) in Q1 2023, closing a stake of 11,877 shares — an estimated $282K sold.

Quantamental Technologies first reported a position in VCYT in Q3 2021 and held it in 4 quarters. The position peaked at $282K in Q4 2022. 232 funds tracked by Wall St. Rank hold VCYT as of Q1 2023.

  • Quantamental Technologies reported no remaining Veracyte position as of Q1 2023 after selling out during the quarter.
  • Quantamental Technologies sold 11,877 Veracyte shares in Q1 2023, an estimated $282K.
  • Quantamental Technologies first reported a position in Veracyte in Q3 2021 and held it in 4 quarters.
  • Quantamental Technologies's Veracyte position peaked at $282K in Q4 2022.
  • 232 funds tracked by Wall St. Rank held Veracyte as of Q1 2023.

Based on Quantamental Technologies's 13F filing for Q1 2023, filed 15 May 2023.